Tumor suppressor p53 gene mutations were significantly more prevalent in CIN colon cancers (76.5%) compared to MSI (28.3%) and GS (16.3%) cancers (χ2 test p = 0.001, Figure 1C). This evidence concerns the gene TP53 and cancer.